CaleeTech

Company Overview

Snapshot

Founded in May 2017 by Igor Gindin, CaleeTech operates with 11–50 employees. The company has secured funding across three rounds from Israel MedicUp and FoodNxt - Innovation Lab. CaleeTech also received a grant from the Israel Innovation Authority.

Business overview

CaleeTech is a biotechnology startup focused on developing innovative solutions for individuals with obesity and diabetes. The company's core technology involves an oral formulation designed to reduce caloric intake by limiting fat and sugar absorption in the small intestine. This product aims to allow users to enjoy meals while lowering blood sugar and fat levels, offering a transient and safe solution. CaleeTech operates within the Health Tech & Life Sciences sector, specifically targeting the pharmaceutical, food tech, and nutrition industries.

Company Intelligence Q&A

Who founded CaleeTech?

CaleeTech was founded by Igor Gindin, who also serves as the CEO.

When was CaleeTech founded?

CaleeTech was founded in May 2017.

What is CaleeTech's primary focus?

CaleeTech specializes in providing novel solutions for people with obesity and diabetes, developing an oral formulation to reduce caloric intake.

Has CaleeTech received any grants?

CaleeTech received a grant from the Israel Innovation Authority.

Which investors have participated in CaleeTech's funding rounds?

CaleeTech has received funding from investors including Israel MedicUp and FoodNxt - Innovation Lab.